drugset
drugset / Trial / NCT01147549

Single Oral Dose of 60 mg [14C]AZD9668 in Healthy Male Volunteers

NCT01147549 ↗

Phase 1 Completed 4 enrolled AstraZeneca
NaSingle-groupOpen-labelBasic science

Summary

The purpose of the study is to characterise the absorption, distribution, metabolism and excretion (ADME) of a single oral dose of \[14C\]AZD9668.

Timeline

Start
2010-06
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Alvelestat Small molecule 60 mg Oral

Indications

No indication recorded.